• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病患者报告结局量表的制定与验证。

Development and validation of the patient-reported outcome scale for chronic kidney disease.

机构信息

School of Nursing, Army Medical University (Third Military Medical University), No. 30 Gaotanyan Street, Shapingba District, Chongqing, 400038, People's Republic of China.

Department of Nephrology, the Key Laboratory for the Prevention and Treatment of Chronic Kidney Disease of Chongqing, Chongqing Clinical Research Center of Kidney and Urology Diseases, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing, 400037, People's Republic of China.

出版信息

Int Urol Nephrol. 2024 Feb;56(2):653-665. doi: 10.1007/s11255-023-03702-1. Epub 2023 Jul 15.

DOI:10.1007/s11255-023-03702-1
PMID:37452989
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10808283/
Abstract

PURPOSE

The patient-reported outcomes (PROs) measuring patient's experience and perception of disease are important components of approach to care. However, no tools are available to assess the PROs of chronic kidney disease (CKD). This study aims to develop and verify a PROs scale to evaluate clinical outcomes in CKD patients.

METHODS

The theoretical structure model and original item pool were formed through a literature review, patient interviews and references to relevant scales. The Delphi method, classical test theory methods and item response theory method were used to select items and adjust dimensions to form the final scale. Altogether 360 CKD patients were recruited through convenience sampling. CKD-PROs could be evaluated from four aspects, namely reliability, content validity, construct validity, responsibility, and feasibility.

RESULTS

The CKD-PROs scale covers 4 domains, including the physiological, psychological, social, and therapeutic domain, and 12 dimensions, 54 items. The Cronbach's α is 0.939, the split reliability coefficient is 0.945, and the correlation of the scores each item and domain's coefficients range from 0.413 to 0.669. The results of structure validity, content validity and reactivity showed that the multidimensional measurement of the scale met professional expectations. The recovery rate and effective rate of the scale were over 99%.

CONCLUSION

The CKD-PROs scale has great reliability, validity, reactivity, acceptability and is capable of being used as one of the evaluation tools for the clinical outcomes of CKD patients.

摘要

目的

患者报告的结局(PROs)衡量患者对疾病的体验和感知,是治疗方法的重要组成部分。然而,目前尚无工具可用于评估慢性肾脏病(CKD)患者的 PROs。本研究旨在开发和验证一种 PROs 量表,以评估 CKD 患者的临床结局。

方法

通过文献回顾、患者访谈和参考相关量表,形成理论结构模型和原始条目库。采用德尔菲法、经典测试理论方法和项目反应理论方法选择条目并调整维度,形成最终量表。通过方便抽样共招募 360 名 CKD 患者。CKD-PROs 可从四个方面进行评估,包括可靠性、内容效度、结构效度、责任和可行性。

结果

CKD-PROs 量表涵盖 4 个领域,包括生理、心理、社会和治疗领域,共 12 个维度,54 个条目。Cronbach's α 为 0.939,分半信度系数为 0.945,各条目和维度得分的相关性系数范围为 0.413 至 0.669。结构效度、内容效度和反应度的结果表明,该量表的多维测量符合专业预期。该量表的恢复率和有效率均超过 99%。

结论

CKD-PROs 量表具有良好的信度、效度、反应度、可接受性,可作为评估 CKD 患者临床结局的评价工具之一。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f9/10808283/a65b2606a6bf/11255_2023_3702_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f9/10808283/aa54eed1ef59/11255_2023_3702_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f9/10808283/cf35ef80b322/11255_2023_3702_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f9/10808283/a65b2606a6bf/11255_2023_3702_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f9/10808283/aa54eed1ef59/11255_2023_3702_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f9/10808283/cf35ef80b322/11255_2023_3702_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6f9/10808283/a65b2606a6bf/11255_2023_3702_Fig3_HTML.jpg

相似文献

1
Development and validation of the patient-reported outcome scale for chronic kidney disease.慢性肾脏病患者报告结局量表的制定与验证。
Int Urol Nephrol. 2024 Feb;56(2):653-665. doi: 10.1007/s11255-023-03702-1. Epub 2023 Jul 15.
2
Development and Validation of the Modified Patient-Reported Outcome Scale for Chronic Obstructive Pulmonary Disease (mCOPD-PRO).《改良慢性阻塞性肺疾病患者报告结局量表(mCOPD-PRO)的制定与验证》
Int J Chron Obstruct Pulmon Dis. 2020 Mar 27;15:661-669. doi: 10.2147/COPD.S240842. eCollection 2020.
3
CHF-PROM: validation of a patient-reported outcome measure for patients with chronic heart failure.CHF-PROM:用于慢性心力衰竭患者的患者报告结局测量的验证。
Health Qual Life Outcomes. 2018 Mar 20;16(1):51. doi: 10.1186/s12955-018-0874-2.
4
The Patient-Reported Outcomes Thermometer-5-Item Scale (5T-PROs): Validation of a New Tool for the Quick Assessment of Overall Health Status in Painful Rheumatic Diseases.患者报告结局温度计5项量表(5T-PROs):一种用于快速评估疼痛性风湿性疾病总体健康状况的新工具的验证
Pain Res Manag. 2018 Oct 23;2018:3496846. doi: 10.1155/2018/3496846. eCollection 2018.
5
Psychometric properties of the Kidney Disease Quality of Life short form 36 (KDQOL-36) scale for the assessment of quality of life in Colombian patients with chronic kidney disease on dialysis.KDQOL-36 量表用于评估哥伦比亚透析慢性肾脏病患者的生活质量:信度、效度和反应度。
Int Urol Nephrol. 2024 Jul;56(7):2337-2350. doi: 10.1007/s11255-024-03940-x. Epub 2024 Feb 20.
6
Development and validation of the hospice professional coping scale among Chinese nurses.中文版护生专业应对量表的编制与信效度检验。
BMC Health Serv Res. 2024 Apr 20;24(1):491. doi: 10.1186/s12913-024-10970-9.
7
Validation of the Rainbow Model of Integrated Care Measurement Tools (RMIC-MTs) in renal care for patient and care providers.验证彩虹综合关怀测量工具(RMIC-MTs)在肾脏关怀中对患者和护理提供者的适用性。
PLoS One. 2019 Sep 19;14(9):e0222593. doi: 10.1371/journal.pone.0222593. eCollection 2019.
8
The PU-PROM: A patient-reported outcome measure for peptic ulcer disease.PU-PROM:一种用于消化性溃疡疾病的患者报告结局测量工具。
Health Expect. 2017 Dec;20(6):1350-1366. doi: 10.1111/hex.12575. Epub 2017 Jun 21.
9
Development and validation of the patient-reported outcome for older people living with HIV/AIDS in China (PROHIV-OLD).开发和验证中国艾滋病毒/艾滋病老年患者报告结局量表(PROHIV-OLD)。
Health Qual Life Outcomes. 2024 Apr 1;22(1):30. doi: 10.1186/s12955-024-02243-0.
10
Validity and reliability of the Patient-Reported Outcomes Measurement Information System (PROMIS®) using computerized adaptive testing in patients with advanced chronic kidney disease.使用计算机自适应测试评估晚期慢性肾脏病患者的患者报告结局测量信息系统(PROMIS®)的有效性和可靠性。
Nephrol Dial Transplant. 2023 May 4;38(5):1158-1169. doi: 10.1093/ndt/gfac231.

引用本文的文献

1
Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop.为临床实践指南界定糖尿病、肥胖症、心血管疾病及慢性肾脏病患者报告的结局——指南研讨会特别工作组的观点
Cardiovasc Diabetol. 2025 Feb 7;24(1):68. doi: 10.1186/s12933-024-02550-2.

本文引用的文献

1
CAD-CAM removable complete dentures: A systematic review and meta-analysis of trueness of fit, biocompatibility, mechanical properties, surface characteristics, color stability, time-cost analysis, clinical and patient-reported outcomes.CAD-CAM 可摘局部义齿:适合性、生物相容性、机械性能、表面特性、颜色稳定性、时间成本分析、临床和患者报告结果的准确性的系统评价和荟萃分析。
J Dent. 2021 Oct;113:103777. doi: 10.1016/j.jdent.2021.103777. Epub 2021 Aug 13.
2
Patient-Reported Outcome Measures in Lymphedema: A Systematic Review and COSMIN Analysis.患者报告结局测量在淋巴水肿中的应用:系统评价和 COMSIN 分析。
Ann Surg Oncol. 2021 Mar;28(3):1656-1668. doi: 10.1245/s10434-020-09346-0. Epub 2020 Nov 28.
3
International consensus statement on allergy and rhinology: rhinosinusitis 2021.
《2021年变应性鼻炎和鼻科学国际共识声明:鼻窦炎》
Int Forum Allergy Rhinol. 2021 Mar;11(3):213-739. doi: 10.1002/alr.22741.
4
Sustainable Development Goals relevant to kidney health: an update on progress.与肾脏健康相关的可持续发展目标:进展情况更新。
Nat Rev Nephrol. 2021 Jan;17(1):15-32. doi: 10.1038/s41581-020-00363-6. Epub 2020 Nov 13.
5
Meaningful Clinical Applications of Patient-Reported Outcome Measures in Orthopaedics.患者报告结局测量在骨科中的有意义的临床应用。
J Bone Joint Surg Am. 2021 Jan 6;103(1):84-91. doi: 10.2106/JBJS.20.00624.
6
Item Response Theory Analysis of the Texas Functional Living Scale.德州功能生活量表的项目反应理论分析。
Arch Clin Neuropsychol. 2021 Jan 15;36(1):135-144. doi: 10.1093/arclin/acaa051.
7
Harnessing the patient voice in prostate cancer research: Systematic review on the use of patient-reported outcomes in randomized controlled trials to support clinical decision-making.挖掘前列腺癌研究中的患者声音:系统综述患者报告结局在支持临床决策的随机对照试验中的应用。
Cancer Med. 2020 Jun;9(12):4039-4058. doi: 10.1002/cam4.3018. Epub 2020 Apr 25.
8
Chronic Kidney Disease Diagnosis and Management: A Review.慢性肾脏病的诊断与管理:综述。
JAMA. 2019 Oct 1;322(13):1294-1304. doi: 10.1001/jama.2019.14745.
9
Harnessing the patient voice in real-world evidence: the essential role of patient-reported outcomes.在真实世界证据中利用患者声音:患者报告结局的重要作用。
Nat Rev Drug Discov. 2019 Sep;18(10):731-732. doi: 10.1038/d41573-019-00088-7.
10
The evolving role of patient preference studies in health-care decision-making, from clinical drug development to clinical care management.患者偏好研究在医疗保健决策中不断演变的作用,从临床药物研发到临床护理管理。
Expert Rev Pharmacoecon Outcomes Res. 2019 Aug;19(4):383-396. doi: 10.1080/14737167.2019.1612242. Epub 2019 May 9.